Total Funding
39
54
Total FundingGrant raised
Growth Score 39 in past quarter
-14 pts
Heat Score 54 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31949
Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.
- Philipp Spycher: Co-founder and CEO
- Isabella Attinger-Toller: Co-founder and VP Translational Research
About the Company
Araris Biotech is a biotechnology company that develops antibody-drug conjugates using a proprietary linker technology designed for efficient payload attachment without antibody engineering. The company's platform enables the creation of stable, homogenous ADCs with improved therapeutic efficacy and reduced side effects. The company focuses on
advancing targeted cancer treatments by streamlining the ADC development process.
